Financial Data and Key Metrics Changes - Total revenue for Q2 2024 was 5.7 million in Q2 2023 [11][14] - Net income attributable to the company was 0.55 per diluted share, compared to a net loss of 0.02 per diluted share in Q2 2023 [17] - Adjusted EBITDA for Q2 2024 was 1.9 million in Q2 2023 [18] Business Line Data and Key Metrics Changes - Revenue from the leasing segment was 4.81 million in the prior year [14] - Revenue from the retail segment surged to 756,000 in the year-ago quarter, driven by the Rhode Island acquisition and increased volumes [14] - Proton therapy revenue decreased by 5% to 2.74 million, but excluding expired contracts, procedures increased by 24% [15] Company Strategy and Development Direction - The company is focusing on expanding its retail segment, as evidenced by the Rhode Island acquisition and new centers in Mexico [9][23] - Plans include building a proton beam radiation therapy center in Rhode Island, which would be the only system between New York City and Boston [10] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, highlighting the strong performance in Q2 and the strategic acquisition in Rhode Island [7][32] - The company anticipates stronger international growth and additional revenue streams from new centers and acquisitions [12][32] Other Important Information - The company ended Q2 2024 with over 2.24 per share [12] - Shareholders' equity increased to 4.17 per share at the end of Q2 2024, up from 3.59 per share at the end of 2023 [20] Q&A Session Summary Question: Confirmation on growth opportunities in direct business and potential service interruptions at Sacred Heart - Management confirmed focus on both leasing and retail segments, with a stronger emphasis on retail opportunities [23] Question: Clarification on the timing of the Rhode Island acquisition - Management confirmed that the acquisition concluded in early May, thus not reflecting a full three months in the reported quarter [25] Question: Insights from the direct relationship and updates on the proton beam project - Management noted delays in the CON application process but expressed confidence in the outcome and highlighted ongoing learning from the new operations [27][28] Question: Marketing strategies for Rhode Island centers and sales pipeline updates - Management indicated a robust sales pipeline and ongoing market engagement to identify new opportunities [30]
American Shared Hospital Services(AMS) - 2024 Q2 - Earnings Call Transcript